Dieter Scherer

This inventor holds 20 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 16 EPO patents, primarily in Semifluorinated Compounds. Top assignees: Novaliq Gmbh, Dermaliq Therapeutics, Inc., Lonza Guangzhou Pharmaceutical Ltd.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter Scherer. Retrieved from https://idiyas.com/inventor/dieter-scherer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 12)

% Patents Active = 95.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 16 (Patent Applications = 22)

Average Co-Inventor Count = 4.1

ph-index = 11

Forward Citations = 272(Granted Patents)

Company Filing History:

Dermaliq Therapeutics, Inc.

patents

1 out of 2

Lonza Guangzhou Pharmaceutical Ltd.

Lts Lohmann Therapie-Systeme Ag

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

Semifluorinated Alkanes

Topical Pharmaceutical Composition

Stabilized Antibody Compositions

Protein Compositions

Ocular Disorders

Therapeutic Systems

Compositions Mixtures

Preparation Methods

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12310977 - Use of semi-fluorinated alkanes in transdermal therapeutic systems (2025-05-27),

2. 12128010 - Semifluorinated compounds and their compositions (2024-10-29),

3. 12005033 - Compositions comprising mixtures of semifluorinated alkanes (2024-06-11),

4. 11987623 - Stabilized antibody compositions (2024-05-21),

5. RE49758 - Stabilised protein compositions based on semifluorinated alkanes (2023-12-19),

6. 11844836 - Topical pharmaceutical composition based on semifluorinated alkanes (2023-12-19),

7. 11583513 - Semifluorinated alkane compositions (2023-02-21),

8. 11357738 - Semifluorinated compounds and their compositions (2022-06-14),

9. 11174236 - Method for preparation of 1,4-sorbitan (2021-11-16),

10. 11154513 - Semifluorinated compounds (2021-10-26),

11. 10813999 - Topical pharmaceutical composition based on semifluorinated alkanes (2020-10-27),

12. 10682315 - Semifluorinated compounds and their compositions (2020-06-16),

13. 10576154 - Semifluorinated alkane compositions (2020-03-03),

14. 10449164 - Methods of treating ocular disorders using semifluorinated alkanes (2019-10-22),

15. 10369117 - Compositions comprising mixtures of semifluorinated alkanes (2019-08-06),

Title: Unveiling the Innovations of Dieter Scherer in Pharmaceutical Compositions

Introduction: Dieter Scherer, a pioneering inventor hailing from Laufen, Switzerland, has made significant contributions to the field of pharmaceutical compositions. With an impressive portfolio of 16 patents under his belt, Scherer's inventive spirit has led to breakthroughs in topical administration and protein stabilization.

Latest Patents:

1. Topical Pharmaceutical Composition based on Semifluorinated Alkanes: Scherer's invention revolutionizes the delivery of active ingredients into the deeper layers of the skin or skin appendages. By incorporating semifluorinated alkanes, this composition facilitates the effective administration of immunosuppressants, anti-infectives, and other agents.

2. Stabilized Protein Compositions based on Semifluorinated Alkanes: Scherer's novel compositions offer improved stability and shelf-life for bioactive polypeptides and proteins. Liquid vehicles utilizing semifluorinated alkanes protect these biomolecules from degradation, making them ideal for topical or parenteral administration.

Career Highlights: Throughout his career, Scherer has made significant strides in the pharmaceutical industry. Having worked with esteemed companies such as Novaliq GmbH and Lonza Guangzhou Pharmaceutical Ltd., he has garnered experience and expertise in developing innovative solutions for drug delivery and protein stabilization.

Collaborations: Scherer's collaborative efforts with industry peers like Bernhard Günther and Bastian Theisinger have further enriched his innovative pursuits. Together, they have explored new frontiers in pharmaceutical compositions, pushing the boundaries of drug development and delivery.

Conclusion: Dieter Scherer's inventive prowess in formulating advanced pharmaceutical compositions underscores his commitment to enhancing medical treatments and therapies. His remarkable contributions to the field continue to pave the way for groundbreaking innovations that benefit both patients and the healthcare industry.

Profile summary based on public USPTO records.